Another dividend increase announcement, this time from by Johnson & Johnson (NYSE: JNJ), the well-known health company.
The increase is from $0.49 to $0.54 per quarter, a 10% boost. This comes as the markets are nervous about the pharmaceutical sector due to the recently-annouced U.S. health care reform. To me, such nervousness is the time when the company is on sale. I own JNJ in my DRiP portfolio, and I am gradually buying more shares using the share purchase plan.